IVAT Proposal In Limbo As Industry Coalition Seeks Audience WIth FDA
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders are seeking clarification on agency concerns regarding industry's in vitro analytical test premarket proposal, following an Oct. 24 meeting between reps from OIVD and the IVAT industry coalition
You may also be interested in...
IVAT Proposal Drafters Consider Alternatives, Faced With FDA Reservations
Industry's in vitro diagnostic analytical test (IVAT) premarket proposal is unlikely to advance in its current form
IVAT Proposal Drafters Consider Alternatives, Faced With FDA Reservations
Industry's in vitro diagnostic analytical test (IVAT) premarket proposal is unlikely to advance in its current form
ASR Rulemaking Will Hinge On Risk Levels; AmpliChip Clarification Awaited
Clarification on the regulation of microarrays as analyte-specific reagents likely will be provided in a letter from FDA to Roche Molecular Diagnostics within the next two weeks